Gray Michael - Insider Stock Trading - OpenInsider

CIK: 1271411 - Address: C/o Imara, Inc., 116 Huntington Avenue, 6Th Floor, Boston, MA 02116

19 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	1	0	-4	-14	4	-31	-55	-20
P	%wins				100	0	0	100	0	0	33
S	%ret	1	1	6	2	2	-8	-11	-19	-18	-9
S	%wins				67	33	83	67	100	100	75

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
2/22/23 20:26	2/22/23	IMRA	Imara Inc.	DE	Health	Drug	Pharmaceutical Preparations	Gray Michael	MA	O	CFO,COO	S	-46	4.67	0	-10	-26	28	D
2/1/23 18:26	1/30/23	IMRA	Imara Inc.	DE	Health	Drug	Pharmaceutical Preparations	Gray Michael	MA	O	CFO,COO	S	-14	3.92	0	-4	-9	37	D
12/15/20 16:26	12/11/20	IMRA	Imara Inc.	DE	Health	Drug	Pharmaceutical Preparations	Gray Michael	MA	O	CFO,COO	M.d	6	4.92	0	1		0	D
12/15/20 16:26	12/11/20	IMRA	Imara Inc.	DE	Health	Drug	Pharmaceutical Preparations	Gray Michael	MA	O	CFO,COO	S.d	-31	25.00	0	-1	-100	0	D
11/12/13 10:02	11/12/13	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	P	29	2.86	2	10	10	107	D	-24	-13	-36	-29	-36	-35	-29	0	0	-4	-14	4	-31	-55
5/7/13 17:25	5/6/13	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	M.dm	122	2.43	2	50	94	103	D	-2	-25	-6	18	8	13	6	-1	6	21	-7	17	9	-41
9/21/12 16:04	9/18/12	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	COO,CFO	M.d	29	1.09	2	26	43	87	D	216	42	-7	-14	-2	-2	1	2	-1	-3	-7	-15	-22	-1
9/21/12 16:04	9/18/12	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	COO,CFO	S.d	-112	4.28	2	-26	-23	87	D	216	42	-7	-14	-2	-2	1	2	-1	-3	-7	-15	-22	-1
4/20/12 16:57	4/18/12	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	COO,CFO	M.dm	64	1.50	3	43	98	87	D	47	18	36	1	7	-3	9	0	-3	-1	-10	7	-15	-37
4/20/12 16:57	4/18/12	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	COO,CFO	S.dm	-215	5.01	3	-43	-33	87	D	47	18	36	1	7	-3	9	0	-3	-1	-10	7	-15	-37
10/2/08 09:55	10/1/08	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	COO,CFO	M.d	8	1.09	0	8	New	8	D	-18	10	-18	-23	-41	-26	-19	-16	1	-6	-27	-34	21	76
1/12/05 10:26	1/10/05	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	M.d	15	1.50	2	10		0	D	361	-10	27	26	15	-16	-11	-4	0	1	-10	-18	-3	-14
1/12/05 10:26	1/10/05	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	S.d	-46	4.62	2	-10	-100	0	D	361	-10	27	26	15	-16	-11	-4	0	1	-10	-18	-3	-14
12/10/04 16:11	12/8/04	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	M.d	15	1.50	3	10		0	D	342	-3	17	14	30	24	23	-5	4	9	-5	-25	-28	-26
12/10/04 16:11	12/8/04	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	S.d	-50	4.97	3	-10	-100	0	D	342	-3	17	14	30	24	23	-5	4	9	-5	-25	-28	-26
12/6/04 09:28	12/2/04	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	M.d	27	1.50	2	18		0	D	385	-8	2	13	48	21	19	19	10	3	1	-21	-25	-21
12/6/04 09:28	12/2/04	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	S.d	-82	4.51	2	-18	-100	0	D	385	-8	2	13	48	21	19	19	10	3	1	-21	-25	-21
9/14/04 14:18	9/13/04	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	M.d	12	1.09	1	11		0	D	572	5	-10	4	46	20	10	6	0	1	-19	9	-19	-6
9/14/04 14:18	9/13/04	CRIS	Curis Inc	DE	Health	BioPrd	Biological Products, (No Diag	Gray Michael	MA	O	CFO	S.d	-51	4.55	1	-11	-100	0	D	572	5	-10	4	46	20	10	6	0	1	-19	9	-19	-6

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact